Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Travere Therapeutics
TVTX
$5.11B
| $322K | ﹤0.01% |
22,070
| – | – |
|
702
Vanguard Total International Bond ETF
BNDX
$82B
| $317K | ﹤0.01% |
5,556
+852
| +18% | +$48.6K |
|
|
ADMS
703
DELISTED
Adamas Pharmaceuticals
ADMS
| $316K | ﹤0.01% |
59,771
+22,279
| +59% | +$115K |
|
704
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $313K | ﹤0.01% |
9,584
-432
| -4% | -$14.3K |
|
705
Fidelity MSCI Industrials Index ETF
FIDU
$2.35B
| $313K | ﹤0.01% |
+5,766
| New | +$312K |
|
706
Oneok
OKE
$55.6B
| $312K | ﹤0.01% |
+5,599
| New | +$298K |
|
707
Acadia Healthcare
ACHC
$2.85B
| $302K | ﹤0.01% |
4,807
-526
| -10% | -$33K |
|
708
Post Holdings
POST
$4.09B
| $302K | ﹤0.01% |
4,252
-286
| -6% | -$21.1K |
|
709
Colgate-Palmolive
CL
$71.9B
| $301K | ﹤0.01% |
3,704
-99
| -3% | -$8.1K |
|
710
HP
HPQ
$24.8B
| $301K | ﹤0.01% |
9,958
+2,203
| +28% | +$70.4K |
|
711
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
| $300K | ﹤0.01% |
2,941
-129
| -4% | -$12.7K |
|
712
iShares MSCI ACWI ex US ETF
ACWX
$11.6B
| $298K | ﹤0.01% |
5,175
-1,545
| -23% | -$88.7K |
|
713
TE Connectivity
TEL
$59.4B
| $298K | ﹤0.01% |
2,201
-148
| -6% | -$19.8K |
|
714
iShares MSCI Emerging Markets Asia ETF
EEMA
$840M
| $297K | ﹤0.01% |
3,212
| – | – |
|
715
Analog Devices
ADI
$176B
| $292K | ﹤0.01% |
1,697
+74
| +5% | +$11.9K |
|
716
iShares MSCI EAFE Value ETF
EFV
$29B
| $292K | ﹤0.01% |
+5,642
| New | +$298K |
|
717
Zebra Technologies
ZBRA
$13.9B
| $292K | ﹤0.01% |
552
-25
| -4% | -$12.5K |
|
718
Enanta Pharmaceuticals
ENTA
$377M
| $291K | ﹤0.01% |
6,601
+258
| +4% | +$12.6K |
|
719
Palo Alto Networks
PANW
$283B
| $291K | ﹤0.01% |
4,704
-1,098
| -19% | -$65.1K |
|
720
Pricesmart
PSMT
$6.08B
| $288K | ﹤0.01% |
+3,167
| New | +$282K |
|
721
Aecom
ACM
$9.61B
| $284K | ﹤0.01% |
4,488
+241
| +6% | +$15.8K |
|
722
Linde
LIN
$222B
| $280K | ﹤0.01% |
970
-1,873
| -66% | -$546K |
|
723
Public Service Enterprise Group
PEG
$38.2B
| $276K | ﹤0.01% |
4,617
-803
| -15% | -$49.6K |
|
724
Vanguard Morningstar Large-Cap ETF
VV
$53.2B
| $275K | ﹤0.01% |
1,370
-2,915
| -68% | -$569K |
|
725
Becton Dickinson
BDX
$46.9B
| $274K | ﹤0.01% |
1,155
+198
| +21% | +$47.5K |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.